The former mainly include sulfonylureas, glinides, dipeptidyl peptidase-IV inhibitors (DPP-4i), and glucagon-like peptide-1 receptor agonists (GLP-1 RA), and the latter mainly include biguanides, thiazolidinediones (TZDs), -glucosidase inhibitors, and sodium-glucose cotransport-2 inhibitors (SGLT-2i)
Improves Overall Health Strengthens the immune system & boosts energy
This 2.5-point increase is driven by rising metabolic risk awareness and early-stage GLP-1 prescription trends
They enhance energy levels and reduce fatigue, helping patients participate more effectively in post-operative rehabilitation
For users who want to verify the math manually, the formula is straightforward
All of these benefits stay consistent as long as I take the medication regularly